Leon Bernal-Mizrachi was appointed the inaugural chair of the Department of Cancer Medicine in the Wake Forest University School of Medicine at Atrium Health Wake Forest Baptist, effective April 1.
Matthew E. BurowJessica ShankZachary PursellMatthew E. Burow, Jessica Shank, and Zachary Pursell were appointed to the leadership team of Tulane Cancer Center.
Ze’ev Ronai, a cancer investigator and director of the Translational Research Institute at Cedars-Sinai, received an Outstanding Investigator Award from NCI.
Jason A. DamskerMichael NoonanJason A. Damsker was appointed professor in the Department of Hematology/Oncology and Michael Noonan was appointed assistant professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center.
Samuel AchilefuJennifer CochranDorin ComaniciuThe National Academy of Engineering elected three cancer researchers—Samuel Achilefu, Jennifer Cochran, Dorin Comaniciu—to its class of 2025, among 128 members and 22 international members.
The governing body of the Cancer Prevention and Research Institute of Texas approved 53 grants totaling more than $67 million to state research institutions to advance the state’s fight against cancer. The grants provide funding for a wide array of cancer projects, including CPRIT Scholar recruitment awards, funding for collaborative core facilities, and support for cancer clinical trials.
Aleksandar Sekulic was named physician-in-chief at the Translational Genomics Research Institute, part of City of Hope.
Boris Naraev, an expert in gastrointestinal, neuroendocrine, and endocrine tumors, joined the Tampa General Hospital Cancer Institute and was appointed as associate professor in the Department of Internal Medicine at the University of South Florida Health Morsani College of Medicine.
Daniel K. Nomura was named editor-in-chief of Molecular Cancer Therapeutics, one of the 10 journals published by the American Association for Cancer Research.
Case Comprehensive Cancer Center was recognized by NCI with a merit award of “outstanding,” 19 months after transitioning to a new director.
